- Home
- PLX vs NCTY Comparison
PLX vs NCTY Comparison
Compare PLX & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- NCTY
- Stock Information
- Founded
- PLX 1993
- NCTY 1999
- Country
- PLX Israel
- NCTY China
- Employees
- PLX N/A
- NCTY N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- NCTY Business Services
- Sector
- PLX Health Care
- NCTY Consumer Discretionary
- Exchange
- PLX Nasdaq
- NCTY Nasdaq
- Market Cap
- PLX 132.5M
- NCTY 157.1M
- IPO Year
- PLX 1998
- NCTY 2004
- Fundamental
- Price
- PLX $1.76
- NCTY $14.70
- Analyst Decision
- PLX
- NCTY
- Analyst Count
- PLX 0
- NCTY 0
- Target Price
- PLX N/A
- NCTY N/A
- AVG Volume (30 Days)
- PLX 382.4K
- NCTY 227.0K
- Earning Date
- PLX 11-14-2024
- NCTY 03-27-2015
- Dividend Yield
- PLX N/A
- NCTY N/A
- EPS Growth
- PLX N/A
- NCTY N/A
- EPS
- PLX N/A
- NCTY 0.84
- Revenue
- PLX $45,667,000.00
- NCTY $25,250,543.00
- Revenue This Year
- PLX N/A
- NCTY N/A
- Revenue Next Year
- PLX $88.94
- NCTY N/A
- P/E Ratio
- PLX N/A
- NCTY $47.63
- Revenue Growth
- PLX N/A
- NCTY 65.70
- 52 Week Low
- PLX $0.82
- NCTY $4.03
- 52 Week High
- PLX $1.90
- NCTY $20.59
- Technical
- Relative Strength Index (RSI)
- PLX 62.98
- NCTY 52.14
- Support Level
- PLX $1.60
- NCTY $13.41
- Resistance Level
- PLX $1.83
- NCTY $19.20
- Average True Range (ATR)
- PLX 0.08
- NCTY 1.83
- MACD
- PLX -0.02
- NCTY -0.44
- Stochastic Oscillator
- PLX 71.15
- NCTY 20.06
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China and other areas.